文献速递主动脉疾病

腔内动脉瘤封堵术治疗腹主动脉瘤的中期结果

Midterm results of endovascular aneurysm sealing to treat abdominal aortic aneurysm.
PubMed 文献 · J Vasc Surg · 2018-05-24

单中心连续150例肾下腹主动脉瘤行腔内动脉瘤封堵术(EVAS),2013年3月至2015年7月,前瞻性收集数据。中位随访687天,24.7%再干预;未解决内漏率IA型1.3%、IB型0.7%、I型2.7%,无III型;7例二次破裂,仅1例发生在符合制造商使用说明(IFU)的动脉瘤中。

要点

  • 中位随访687天,37例(24.7%)再干预。
  • 未解决内漏:IA型1.3%、IB型0.7%、I型2.7%,无III型。
  • 7例二次破裂,仅1例发生在符合IFU的动脉瘤中。

核心结论

  • 未解决内漏率令人满意地低。
  • 二次破裂发生率值得关注;但遵守IFU时发生率很低。
  • 本研究结果提示在IFU范围内操作可获得更好的临床结果。

研究设计与样本

  • 单中心队列研究,报告150例连续EVAS治疗完整肾下腹主动脉瘤的早期临床结果、技术改进和学习曲线。
  • 病例实施于2013年3月至2015年7月,前瞻性收集术前、围术期和术后数据。

主要发现

  • 队列中位年龄76.6岁(四分位距70.2-80.9岁),男性87.3%。
  • 中位动脉瘤直径62.0 mm(四分位距58.0-69.0 mm)。
  • 不良瘤颈形态见于69例(46.0%)患者,包括瘤颈长度<10 mm(17.3%)、瘤颈直径>32 mm或<18 mm(8.7%)、瘤颈成角>60度(15.3%)。
  • 中位随访687天(四分位距463-897天);37例(24.7%)再干预。
  • 未解决内漏率:IA型1.3%、IB型0.7%、I型2.7%;无III型内漏。

临床怎么用

  • 本研究结果提示在IFU范围内操作可获得更好的临床结果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endovascular aneurysm sealing (EVAS) represents a novel approach to the treatment of abdominal aortic aneurysms. It uses polymer technology to achieve an anatomic seal within the sac of the aneurysm. This cohort study reports the early clinical outcomes, technical refinements, and learning curve during the initial EVAS experience at a single institution. METHODS: Results from 150 consecutive EVAS cases for intact, infrarenal abdominal aortic aneurysms are reported here. These cases were undertaken between March 2013 and July 2015. Preoperative, perioperative, and postoperative data were collected for each patient prospectively. RESULTS: The median age of the cohort was 76.6 years (interquartile range, 70.2-80.9 years), and 87.3% were male. Median aneurysm diameter was 62.0 mm (IQR, 58.0-69.0 mm). Adverse neck morphology was seen in 69 (46.0%) patients, including aneurysm neck length <10 mm (17.3%), neck diameter >32 mm or <18 mm (8.7%), and neck angulation >60 degrees (15.3%). Median follow-up was 687 days (IQR, 463-897 days); 37 patients (24.7%) underwent reintervention. The rates of unresolved endoleak are 1.3% type IA, 0.7% type IB, and 2.7% type I. There were no type III endoleaks. There have been seven secondary ruptures in this cohort; all but one of these patients survived after reintervention. Only one rupture occurred in an aneurysm that had been treated within the manufacturer's instructions for use (IFU). CONCLUSIONS: The rate of unresolved endoleaks is satisfactorily low. The incidence of secondary rupture is of concern; however, when the IFU are adhered to, the rate is very low. The results of this study suggest that working within the IFU yields better clinical results.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Stenson KM, Patterson BO, Grima MJ, et al. Midterm results of endovascular aneurysm sealing to treat abdominal aortic aneurysm. J Vasc Surg. 2018. PMID: 29804737. doi:10.1016/j.jvs.2018.04.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。